Search research articles
Contact Us
Filters
Showing results (201-210 of 397) with videos related to
Page
of 40
Sort By:
Journal of Immunotherapy and Precision Oncology
|
December 8, 2025
Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration
Lee S Rosen, Christian Ottensmeier, Maria Hawkins, et al.
The Lancet. Oncology
|
April 22, 2014
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
David S Hong, David Hui, Eduardo Bruera, et al.
Anticancer Research
|
April 30, 2014
Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program
Ming-Mo Hou, Xiaochun Liu, Jennifer Wheler, et al.
Investigational New Drugs
|
June 13, 2013
Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer
Prasanth Ganesan, Sarina Piha-Paul, Aung Naing, et al.
European Journal of Endocrinology
|
October 3, 2013
Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center
Montserrat Ayala-Ramirez, Sina Jasim, Lei Feng, et al.
Oncotarget
|
August 4, 2016
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials
J Andrew Livingston, Kenneth R Hess, Aung Naing, et al.
British Journal of Cancer
|
April 22, 2023
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors
Jason J Luke, Marwan Fakih, Charles Schneider, et al.
Investigational New Drugs
|
November 4, 2014
Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors
Gerald S Falchook, Jennifer J Wheler, Aung Naing, et al.
Journal of Hematology & Oncology
|
January 1, 2020
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine
Apostolia-Maria Tsimberidou, David S Hong, Jennifer J Wheler, et al.
Cancer
|
October 30, 2022
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors
Aung Naing, Alain P Algazi, Gerald S Falchook, et al.
Page
of 40
Search research articles
Search
Showing results (201-210 of 397) with videos related to
Sort By:
Page
of 40
Journal of Immunotherapy and Precision Oncology
|
December 8, 2025
Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration
Lee S Rosen, Christian Ottensmeier, Maria Hawkins, et al.
The Lancet. Oncology
|
April 22, 2014
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
David S Hong, David Hui, Eduardo Bruera, et al.
Anticancer Research
|
April 30, 2014
Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program
Ming-Mo Hou, Xiaochun Liu, Jennifer Wheler, et al.
Investigational New Drugs
|
June 13, 2013
Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer
Prasanth Ganesan, Sarina Piha-Paul, Aung Naing, et al.
European Journal of Endocrinology
|
October 3, 2013
Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center
Montserrat Ayala-Ramirez, Sina Jasim, Lei Feng, et al.
Oncotarget
|
August 4, 2016
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials
J Andrew Livingston, Kenneth R Hess, Aung Naing, et al.
British Journal of Cancer
|
April 22, 2023
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors
Jason J Luke, Marwan Fakih, Charles Schneider, et al.
Investigational New Drugs
|
November 4, 2014
Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors
Gerald S Falchook, Jennifer J Wheler, Aung Naing, et al.
Journal of Hematology & Oncology
|
January 1, 2020
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine
Apostolia-Maria Tsimberidou, David S Hong, Jennifer J Wheler, et al.
Cancer
|
October 30, 2022
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors
Aung Naing, Alain P Algazi, Gerald S Falchook, et al.
Page
of 40